Dr. Graham Merry will be presenting the TORPA study data and a summary of the Photospectra treatment clinic results at WALT 2012. This will be at Surfers Paradise on September 29th.

This international meeting of scientists and clinicians will hear the latest results from the Off Label use of PBM in dry AMD that has been provided by Dr. Merry to more than double the amount of patients that were assessed in the TORPA trial.
This new data compliments the significant results from TORPA and provides further evidence of the efficacy and safety of PBM for patients with dry AMD.